Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Summary by Ground News
Vaccine maker Indian Immunologicals (IIL) has received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (DCA) for manufacturing Measles-Rubella (MR) vaccine. IIL is collaborating with Vietnam's Center for Research and Production of Vaccines and Biologicals, also known as Polyvac.

1 Articles

The HinduThe Hindu
Lean Left

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Vietnam’s Center for Research and Production of Vaccines and Biologicals, also known as Polyvac, will be supplying the measles vaccine component, while the rubella vaccine component will be produced by IIL to manufacture a combined MR vaccine.

·Chennai, India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hindu broke the news in Chennai, India on Monday, March 27, 2023.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Asia icon

Asia

Measles icon

Measles

Vaccines icon

Vaccines

Vietnam icon

Vietnam

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal